Cleerly LABS vs Us2.ca

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Cleerly LABS

by Cleerly

Us2.ca

by Eko.Ai Pte Ltd. D/B/A Us2.Ai

AI Verdict

These two tools are adjacent competitors within the broader field of cardiology AI, as they both leverage AI for cardiac imaging analysis. Cleerly LABS focuses on analyzing coronary CT angiography (CCTA) to assess coronary artery disease, while Us2.ca automates the analysis of echocardiography for a wider range of cardiac structural and functional parameters and disease detection. Therefore, the choice between them depends on the specific imaging modality and clinical question at hand.

Choose Cleerly LABS if…

Choose Cleerly LABS if your primary need is a detailed, AI-powered analysis of coronary CT angiography (CCTA) to precisely quantify and characterize atherosclerosis and stenosis. This tool is ideal for clinicians focused on personalized heart disease management, including tracking disease progression over time and refining risk assessment based on comprehensive plaque assessment.

View Cleerly LABS →

Choose Us2.ca if…

Choose Us2.ai if you require fully automated, real-time analysis of echocardiograms to significantly enhance workflow efficiency and diagnostic accuracy across a wide range of cardiac conditions. This platform is best suited for practices aiming to quickly generate comprehensive, structured cardiac reports with AI-powered disease detection for conditions like heart failure or valvular disease.

View Us2.ca →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Cleerly LABS	Us2.ca
Pricing	Per analysis	Contact for pricing
Deployment	Cloud-based (AWS), web-based application, with on-site Cleerly Proxy for data transfer.	Cloud, On-premise
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Cleerly LABS	Us2.ca
Tool Name	Cleerly LABS	Us2.ca
Company	Cleerly	Eko.Ai Pte Ltd. D/B/A Us2.Ai
Primary Imaging Modality	Coronary CT Angiography (CCTA)	Echocardiography
Core Function	Comprehensive analysis of CCTA to detect, quantify, and characterize atherosclerosis and stenosis	Fully automated echocardiography analysis, delivering comprehensive, structured cardiac reports
Specific Disease/Condition Assessment	Atherosclerosis, Stenosis, Ischemia (with Cleerly ISCHEMIA module), Personalized heart disease risk	Cardiac Amyloidosis, Heart Failure, Aortic Stenosis, Pulmonary Hypertension, Comprehensive cardiac structural and functional parameters
Key Output/Visualization	Comprehensive coronary plaque assessment (volume, type), 3D visualization of coronary arteries, Tracking disease progression	Structured cardiac reports, Explainable AI with editable annotations and visual overlays, Guideline-based measurements

Videos

Demos, reviews, and walkthroughs featuring Cleerly LABS and Us2.ca.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What imaging modalities do Cleerly LABS and Us2.ai analyze?

Cleerly LABS is an AI-powered software designed for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis. Us2.ai is an AI platform that fully automates the analysis of echocardiography images.

What specific clinical insights or disease detections do these tools offer?

Cleerly LABS provides comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, and can detect ischemia with its ISCHEMIA module, aiding in personalized heart disease risk assessment and tracking progression. Us2.ai offers AI-powered disease detection for conditions such as Cardiac Amyloidosis, Heart Failure, Aortic Stenosis, and Pulmonary Hypertension, along with comprehensive cardiac structural and functional parameters.

How do the pricing and insurance coverage differ between Cleerly LABS and Us2.ai?

Cleerly LABS is priced per analysis, with a retail price of $1500, currently offered at a discounted rate of $750, excluding the separate CCTA scan cost. Some insurance coverage is available, but it often results in out-of-pocket expenses ranging from $1000-$1500 total. Us2.ai's pricing is not publicly disclosed, requiring direct contact for details.

How do these tools integrate with existing clinical workflows and systems?

Cleerly LABS integrates with PACS, RIS, and EHR via its Cleerly Proxy for data transfer. Us2.ai integrates with ultrasound devices, PACS, CVIS, and EMR systems.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Cleerly LABS or Us2.ca

Backers

Who funded each tool's parent company.